Loews Operating Cash Flow decreased by 88.3% to $72.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 90.2%, from $736.00M to $72.00M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 5.7% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $409.00M | $1.13B | $947.00M | $423.00M | $1.02B | $1.25B | $622.00M | $719.00M | $1.43B | $1.28B | $477.00M | $198.00M | $952.00M | $934.00M | $941.00M | $736.00M | $1.01B | $920.00M | $617.00M | $72.00M |
| QoQ Change | — | +177.0% | -16.4% | -55.3% | +141.8% | +21.8% | -50.1% | +15.6% | +99.4% | -10.9% | -62.6% | -58.5% | +380.8% | -1.9% | +0.7% | -21.8% | +36.7% | -8.5% | -32.9% | -88.3% |
| YoY Change | — | — | — | — | +150.1% | +10.0% | -34.3% | +70.0% | +40.2% | +2.5% | -23.3% | -72.5% | -33.6% | -26.9% | +97.3% | +271.7% | +5.7% | -1.5% | -34.4% | -90.2% |